skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.12d (Release date: 2017-12-26)
SearchBox Top
SearchBox Bottom
WT1 126-134 Peptide Vaccine (Code C61442)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: WT1 126-134 Peptide Vaccine

Definition: A synthetic peptide vaccine consisting of the amino acids 126 through 134 of the human Wilms' Tumor protein-1 (WT1) with potential antitumor activity. WT1, a tumor associated antigen, is overexpressed in most types of leukemia and in a variety of solid cancers. Vaccination with WT1 126-134 peptide vaccine may induce a WT1-specific cytotoxic T-lymphocyte (CTL) response against WT1 expressing cells, resulting in cell lysis and inhibition of cancer cell proliferation.

Display Name: WT1 126-134 Peptide Vaccine

Label: WT1 126-134 Peptide Vaccine

NCI Thesaurus Code: C61442 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C1831770  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
WT1 126-134 Peptide Vaccine

External Source Codes: 
PDQ Closed Trial Search ID 472216
PDQ Open Trial Search ID 472216 (check for NCI PDQ open clinical trial info)
UMLS CUI C1831770

Other Properties:
     Name Value (qualifiers indented underneath)
code C61442
Contributing_Source CTRP
Legacy_Concept_Name WT1_126-134_Peptide_Vaccine
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom